Professor Graham Mann co-leads a highly translational NHMRC program on melanoma, at Melanoma Institute Australia, and the Australian Melanoma Genome Project. The program is engaged in all aspects of melanoma control, from the genetics of melanoma risk and its environmental and psychological aspects, to the use of molecular markers and targets to improve the diagnosis and treatment of melanoma. Based at the Westmead Institute, where he co-directs the Centre for Cancer Research, he is Chair of the University of Sydney Cancer Research Network, and a member of the Scientific Steering Committee of the International Cancer Genome Consortium (ICGC).